Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Echocardiography × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 13 Breast Neoplasms 9 Lymphoma, Non-Hodgkin 5 Lymphoma 4 Heart Failure 4 Neoplasms 3 Prostatic Neoplasms 2 Multiple Myeloma 2 Lymphoma, B-Cell 2 Leukemia 2 Heart Diseases 2 Burkitt Lymphoma 2 Ventricular Dysfunction, Left 1 Ventricular Dysfunction 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Peritoneal Neoplasms 1 Obesity 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Metastatic Solid Tumors 1 Metabolic Syndrome 1 Mesothelioma 1 Memory Disorders 1 Melanoma 1 Lymphoproliferative Disorders 1

Interventions

pembrolizumab 268 Nivolumab 241 Ipilimumab 221 aldesleukin 126 Cyclophosphamide 126 Interleukin-2 93 trametinib 76 dabrafenib 68 Dacarbazine 68 Temozolomide 66 fludarabine 64 Vemurafenib 64 fludarabine phosphate 56 Biopsy 45 Radiosurgery 43 sargramostim 40 Bevacizumab 40 binimetinib 39 incomplete Freund's adjuvant 37 Paclitaxel 35 atezolizumab 34 Radiotherapy 34 Cisplatin 34 Blood Specimen Collection 33 encorafenib 32 Magnetic Resonance Spectroscopy 32 cobimetinib 31 Specimen Handling 31 Introns 31 Carboplatin 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡